Investing in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Learn MoreThanks to spectacular research-driven advances, more than 18 million people in the United States and millions more worldwide are cancer survivors living with, through, and beyond their disease.
Learn MoreRead the stories of cancer survivors and patients featured in the new AACR Cancer Disparities Progress Report 2024.
Read the ReportMore than 25,000 cases of brain and other nervous system cancers are expected to be diagnosed in the U.S. this year. May is Brain Cancer Awareness Month. Learn more about these cancers.
Learn MoreGet updates on research driven advances in cancer science and medicine including the recent AACR Annual Meeting 2024 in San Diego on the AACR Blog.
Read the AACR BlogThe current issue of Leading Discoveries magazine is available with articles on CAR T-cell pioneer Carl H. June, MD, FAACR, research updates from the AACR journals and scientific meetings, and more.
Read Leading DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through July 10. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2024 outlines the complex interplay of factors that drive and perpetuate cancer health disparities and calls for a collaborative approach to achieve health equity.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Winn, chair of the AACR Cancer Disparities Progress Report 2024 steering committee, discusses the many factors that drive and perpetuate cancer health disparities.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More